0001848416 false A1 0001848416 2022-08-18 2022-08-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 18, 2022

 

VERANO HOLDINGS CORP.

(Exact Name of Registrant as Specified in its Charter)

 

 

British Columbia   000-56342   98-1583243
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

415 North Dearborn Street, 4th Floor,

Chicago, Illinois 60654

(Address of Principal Executive Offices) (Zip Code)

 

(312) 265-0730

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
N/A        

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 8.01 Other Events.

 

On August 18, 2022, Verano Holdings Corp. (the “Company”) issued a press release announcing the opening of MÜV Hollywood on Friday, August 19, 2022, which is the Company’s 56th dispensary in Florida and 110th dispensary nationwide. A copy of such press release is filed as Exhibit 99.1 to this report

 

Additionally, on August 19, 2022, the Company issued a press release announcing the opening of Zen Leaf Clarksburg on Friday, August 19, 2022, which is the Company’s 4th dispensary in West Virginia and 111th dispensary nationwide. A copy of such press release is filed as Exhibit 99.2 to this report.

 

The information furnished under this item 8.01, including Exhibits 99.1 and 99.2 incorporated by reference herein, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release issued on August 18, 2022
99.2   Press Release issued on August 19, 2022
104   Cover Page Interactive Data File (embedded within the inline XRBL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VERANO HOLDINGS CORP.
       
Date: August 19, 2022 By: /s/ Darren Weiss
    Name: Darren Weiss
    Title: Chief Operating Officer, Chief Legal Officer, General Counsel & Secretary

 

 

 

Exhibit 99.1

 

A black and white logo

Description automatically generated with low confidence

 

Verano Announces the Opening of MÜV Hollywood, the Company’s 56th Florida Location and 110th Nationwide

 

MÜV Hollywood is the third MÜV dispensary location in Broward County and ninth to open in Florida since late June, underscoring the Company’s ongoing retail expansion across the state
The dispensary is located on high-traffic Taft Road, a thoroughfare with an average daily traffic count of over 16,000 cars1
Verano’s active operations span 13 states, comprised of 110 dispensaries and 13 cultivation and processing facilities with more than 1 million square feet of cultivation capacity

 

CHICAGO – August 18, 2022 – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV Hollywood dispensary on Friday, August 19, 2022, the Company’s 56th Florida dispensary and 110th nationwide. MÜV Hollywood, located at 6661 Taft Road, is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

 

MÜV Hollywood is conveniently located on north Taft Street within the Hollywood Festival Shopping Center, a community fixture with an abundance of shopping staples and local eateries. Minutes to the east is the Boardwalk, a tourist destination featuring a two-mile expanse of wide boardwalk built to accommodate walkers, joggers, and bikers that offers expansive views of the Atlantic Ocean.

 

“MÜV Hollywood is a dispensary we have been looking forward to opening for quite some time, given its proximity to two of the state’s most densely populated counties - Broward and Miami-Dade,” said John Tipton, President of Verano. “Our team is ready and excited to welcome the robust local medical patient community to MÜV Hollywood, where they will experience our efficient express pickup and delivery options, high quality products, and world-class care.”

 

As a demonstration of Verano’s commitment to provide a convenient and reliable experience for Florida patients, MÜV dispensaries feature online menus for effortless browsing of their extensive, award-winning product selection, including the Company’s signature Verano Reserve flower line. The Company also offers one-on-one virtual and in-store consultations at no cost to the patient and provides patient-centric concierge services via phone (833-880-5421), email, web chat and text to address patient questions and inquiries. For additional convenience and accessibility, patients can choose to order ahead at muvfl.com or through the MÜV mobile application available in the Google Play and Apple App stores for express in-store pickup.

 

MÜV’s comprehensive product selection includes edibles, chocolates and lozenges, flower, pre-rolls, an array of vaporizer pens, concentrates, metered-dose inhalers, topicals and oral sprays; along with patented encapsulation formulations in its EnCaps™ capsules, tinctures, 72-hour transdermal patches and transdermal gels.

 

For more information about MÜV Hollywood medical cannabis dispensary, visit muvfl.com.

 

1 Florida Department of Transportation

 

 
 

 

About Verano

 

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia™, Encore™, and MÜV. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

 

Contacts:

 

Media

Verano

Grace Bondy

Manager, Communications

Grace.Bondy@verano.com

 

Investors

Verano

Julianna Paterra, CFA

Director, Investor Relations

Julianna.Paterra@verano.com

 

Forward Looking Statements

 

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

 

 

 

 

Exhibit 99.2

 

A black and white logo

Description automatically generated with low confidence

 

Verano Announces the Opening of Zen Leaf Clarksburg, the Company’s Fourth West Virginia Dispensary and 111th Location Nationwide

 

Zen Leaf Clarksburg is located at 254 Emily Drive, a busy thoroughfare with an average daily traffic count of 17,520 vehicles1
The dispensary is based in Harrison County, which has a population over 65,0002
Verano’s active operations span 13 states, comprised of 111 dispensaries and 13 cultivation and processing facilities with more than 1 million square feet of cultivation capacity

 

CHICAGO, August 19, 2022 – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of Zen Leaf Clarksburg on Friday, August 19, 2022, the Company’s fourth dispensary in West Virginia and 111th nationwide. Zen Leaf Clarksburg, located at 254 Emily Drive, is open Wednesday through Saturday from 11 a.m. to 7 p.m. and Sunday from 10 a.m. to 4 p.m., local time.

 

Zen Leaf Clarksburg joins Verano’s three additional West Virginia Zen Leaf locations in Morgantown, Westover and Wheeling. According to West Virginia’s Office of Medical Cannabis, there are currently over 11,400 approved medical cannabis patients in the state. West Virginia medical cannabis sales are projected to reach $29 million by 2026, as reported by MJBiz Factbook 2022.

 

“We’re excited to open Zen Leaf Clarksburg, our fourth dispensary in West Virginia, to continue serving the state’s growing medical cannabis community,” said George Archos, Verano Founder and Chief Executive Officer. “With the addition of Zen Leaf Clarksburg, we are now well-positioned to serve patients in central West Virginia, and look forward to welcoming the medical cannabis community to experience our patient-centric hospitality and care.”

 

Across West Virginia, Verano has permits issued by West Virginia’s Office of Medical Cannabis to operate a cultivation and processing facility, along with seven total medical cannabis dispensaries that are projected to continue opening in 2022 and 2023, subject to customary approvals.

 

As a demonstration of Verano’s commitment to provide a convenient and reliable experience for West Virginia patients, Zen Leaf offers one-on-one virtual and in-store consultations at no cost to the patient, and provides patient-centric concierge services via phone (304-557-1141), email, web chat and text to address patient questions and inquiries.

 

For more information about Zen Leaf Clarksburg medical cannabis dispensary, visit ZenLeafDispensaries.com.

 

 

1 West Virginia Department of Transportation

2 United States Census Bureau

 

 
 

 

About Verano

 

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia™, Encore™, and MÜV. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

 

Contacts:

 

Media

Verano

Grace Bondy

Manager, Communications

Grace.Bondy@verano.com

 

Investors

Verano

Julianna Paterra, CFA

Director, Investor Relations

Julianna.Paterra@verano.com

 

Forward Looking Statements

 

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###